Next Article in Journal
Quantum Iterative Reconstruction for Low-Dose Ultra-High-Resolution Photon-Counting Detector CT of the Lung
Next Article in Special Issue
24 h Holter ECG Monitoring of Patients with Rheumatoid Arthritis—A Potential Role for a Precise Evaluation of QT Interval Duration and Associated Arrhythmic Complications
Previous Article in Journal
Negative Venous Leg Ultrasound in Acute Pulmonary Embolism: Prevalence, Clinical Characteristics and Predictors
Previous Article in Special Issue
Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Volume 12
Issue 2
10.3390/diagnostics12020521
diagnostics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Diagnostics 2021, 11(12), 2363.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363

by
Iván Ferraz-Amaro
1,2,*,
Alfonso Corrales
3,4,
Belén Atienza-Mateo
3,4,
Nuria Vegas-Revenga
3,
Diana Prieto-Peña
3,4,
Julio Sánchez-Martín
3,4,
Cristina Almeida
5,
Juan Carlos Quevedo-Abeledo
5,
Ricardo Blanco
3,4 and
Miguel Á. González-Gay
3,4,6,*
1
Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain
2
Internal Medicine Department, University of La Laguna, 38071 Tenerife, Spain
3
Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain
4
Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39011 Santander, Spain
5
Division of Rheumatology, Hospital Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain
6
Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa
*
Authors to whom correspondence should be addressed.
Diagnostics 2022, 12(2), 521; https://doi.org/10.3390/diagnostics12020521
Submission received: 29 December 2021 / Accepted: 7 January 2022 / Published: 18 February 2022
(This article belongs to the Special Issue Diagnosis of Rheumatoid Arthritis)
Browse Figure
Versions Notes
In the original article [1], there was a mistake in Figure 1 as published. Due to an error in the proofreading stage, ROC curves in that figure do not represent the exact curves. The corrected Figure 1 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.

Reference

  1. Ferraz-Amaro, I.; Corrales, A.; Atienza-Mateo, B.; Vegas-Revenga, N.; Prieto-Peña, D.; Sánchez-Martín, J.; Almeida, C.; Quevedo-Abeledo, J.C.; Blanco, R.; González-Gay, M.Á. SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363. [Google Scholar] [CrossRef] [PubMed]
Diagnostics 12 00521 g001 550
Figure 1. Relationship of SCORE and SCORE2 with cIMT and carotid plaque.
Figure 1. Relationship of SCORE and SCORE2 with cIMT and carotid plaque.
Diagnostics 12 00521 g001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ferraz-Amaro, I.; Corrales, A.; Atienza-Mateo, B.; Vegas-Revenga, N.; Prieto-Peña, D.; Sánchez-Martín, J.; Almeida, C.; Quevedo-Abeledo, J.C.; Blanco, R.; González-Gay, M.Á. Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363. Diagnostics 2022, 12, 521. https://doi.org/10.3390/diagnostics12020521

AMA Style

Ferraz-Amaro I, Corrales A, Atienza-Mateo B, Vegas-Revenga N, Prieto-Peña D, Sánchez-Martín J, Almeida C, Quevedo-Abeledo JC, Blanco R, González-Gay MÁ. Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363. Diagnostics. 2022; 12(2):521. https://doi.org/10.3390/diagnostics12020521

Chicago/Turabian Style

Ferraz-Amaro, Iván, Alfonso Corrales, Belén Atienza-Mateo, Nuria Vegas-Revenga, Diana Prieto-Peña, Julio Sánchez-Martín, Cristina Almeida, Juan Carlos Quevedo-Abeledo, Ricardo Blanco, and Miguel Á. González-Gay. 2022. "Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363" Diagnostics 12, no. 2: 521. https://doi.org/10.3390/diagnostics12020521

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop